Medical Researches
Possibly Effective
Based on 19 Researches
We observed a fascinating case involving a male in his 40s who experienced persistent inflammatory back pain for three months. Despite having a negative test for HLA-B27, a marker often associated with axial spondyloarthritis, clinical assessments suggested possible underlying issues.
The clinical investigation led to an MRI, which confirmed bilateral symmetrical sacroiliitis. Interestingly, further tests showed he had very low vitamin D levels along with elevated parathyroid hormone—indicating a possible deficiency impacting his condition.
After starting treatment with vitamin D alongside nonsteroidal anti-inflammatory drugs (NSAIDs), he experienced notable relief from his symptoms. His condition improved significantly, and follow-up tests indicated that his vitamin D levels had normalized.
This case demonstrates the potential benefits of vitamin D in managing back pain, especially when classical markers are inconclusive. It highlights how a thorough diagnosis can reveal interconnected health issues and improve treatment outcomes.
Read More
Vitamin D aids back pain reliefAdult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience.
Significant relevance to treatment
We conducted a retrospective review to uncover how vitamin D treatment impacts back pain in individuals diagnosed with adult-onset hypophosphatemic osteomalacia. In our exploration, we found that eight patients, primarily experiencing widespread musculoskeletal pain, were assessed over a span from January 2011 to December 2019.
Each patient presented with low phosphorus levels, elevated alkaline phosphatase, and indicative imaging results. Notably, back pain was reported as the most common complaint, along with muscle weakness in over half of the cases. Our findings highlighted the effectiveness of vitamin D in tandem with phosphorus supplementation, as all patients reported significant improvements in pain, muscle strength, and gait after receiving treatment.
Importantly, we noted that the specific diagnosis of each patient varied. In six cases, treatment was prompted by adefovir-induced Fanconi syndrome, while the remaining two patients had tumor-induced osteomalacia and light-chain nephropathy. This variation indicates the diverse etiologies of hypophosphatemic osteomalacia, further emphasizing the importance of targeted treatment based on individual needs.
In conclusion, our study suggests that vitamin D, especially when combined with phosphorus, plays a crucial role in alleviating back pain associated with this condition. By enhancing the understanding of the relationship between vitamin D treatment and back pain, we aim to shed light on effective management strategies for those suffering from similar symptoms.
Read More
We aimed to find out how docosahexaenoic acid (DHA), a key omega-3 fatty acid, could affect intervertebral disc (IVD) degeneration, a common cause of lower back pain. In our study, we used a group of 12 rats, all of whom underwent a procedure to induce disc degeneration.
After the injury, half of the rats were given a daily supplement of omega-3 fatty acids, while the other half received only a sugar solution as control. Over the course of the study, we measured various outcomes related to inflammation and disc health.
We observed that the omega-3 group showed a significant reduction in blood markers associated with inflammation. Additionally, the results indicated that those receiving DHA were less affected by disc dehydration, and the tissue damage due to the induced injury was noticeably less severe in this group.
Overall, this suggests that increasing our intake of omega-3 fatty acids, like DHA, may offer protective effects against the degeneration of intervertebral discs and could potentially ease back pain related to this condition.
Read More
We conducted a clinical trial to assess whether omega-3 fatty acids, particularly docosahexaenoic acid (DHA), could alleviate back pain associated with dysmenorrhea in young women. Our study involved 36 participants aged 18 to 22, who were divided into two groups. One group received a daily dose of fish oil containing DHA while the other received a placebo over three months.
After the supplementation, we observed a notable reduction in pain levels, as measured by a visual analogue scale. The fish oil group reported a score of 20.9, significantly lower than the 61.8 from the placebo group, showcasing a clear advantage of the fish oil treatment. Moreover, participants experienced a marked reduction in both back and abdominal pain.
Those taking the fish oil also needed fewer rescue doses of ibuprofen, suggesting that DHA may play a beneficial role in managing pain symptoms. However, it’s important to note that while our findings indicate a reduction in pain, distinguishing the isolated effect of DHA from eicosapentaenoic acid (EPA) was not possible in this study, as both were present in the fish oil used.
Overall, we found that dietary supplementation with fish oil rich in omega-3s could be a promising approach for young women suffering from dysmenorrhea-related back pain, although further studies might be necessary to explore the specific contributions of each fatty acid.
Read More
Eicosapentaenoic acid alleviates back painEicosapentaenoic Acid-Induced Autophagy Attenuates Intervertebral Disc Degeneration by Suppressing Endoplasmic Reticulum Stress, Extracellular Matrix Degradation, and Apoptosis.
Strong relevance to back pain
We explored how eicosapentaenoic acid (EPA) might help in treating intervertebral disc degeneration (IDD), a major contributor to back pain. Research highlights that this condition often involves endoplasmic reticulum (ER) stress and breakdown of the extracellular matrix (ECM), key processes that worsen IDD. Our investigation demonstrated that EPA can promote autophagy, a process that helps cells clean up and maintain balance within the ECM.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Read More
User Reviews
The pain and vigour I have from multiple sclerosis and a car accident five years ago have been challenging. My back was operated on and has been stiff. I have experienced significant back pain, but since taking Carlsons D3-vitamin, my wellness has greatly improved. I rarely need pain pills now. My life has changed positively; I feel energised and only need 7 hours of sleep instead of 10-12. I recommend consulting a knowledgeable doctor about this vitamin.
Read More
I'm very pleased! My doctor in Finland recommended this D3 supplement last year for my multiple sclerosis. Since taking one capsule daily, I have more energy and no longer feel tired. Remarkably, my back pain has eased, and I've avoided flu this past year! Previously, migraines required medication weekly, but now those have disappeared. I'm truly grateful for this product.
Read More
A must for people living in Finland! After a month of daily intake, I have noticed a significant reduction in back pain and more vitality. While I can't say for certain it's solely due to the vitamin D, I strongly recommend this specific product as it is primarily derived from fish oil rather than synthetic components.
Read More
Good for daily use; it has really improved my vitamin D levels and supported my joint pains, including back pain.